Lutris Pharma
Venture Round in 2025
Lutris Pharma is an Israel-based biopharmaceutical company focused on improving anti-cancer therapy. It develops drugs to enhance treatment effectiveness, including a proprietary topical B-Raf inhibitor LUT014 that enables administration of epidermal growth factor receptor inhibitors without the cutaneous side effects that typically interrupt therapy. Founded in 2015 and based in Tel Aviv-Yafo, Lutris Pharma aims to improve treatment continuity and patient quality of life for those treated with EGFR inhibitors.
BioProtect
Venture Round in 2023
BioProtect specializes in developing and commercializing biodegradable balloon spacers to protect normal tissue during cancer radiation therapy. Its flagship product, ProSpace, has demonstrated superior efficacy and safety in protecting the rectum during prostate cancer radiotherapy. BioProtect's technology platform caters to a wide range of applications for unmet clinical needs.
Althea Medical
Pre Seed Round in 2023
Althea Medical is a medical device company based in Tel Aviv, Israel, founded in 2020. It focuses on developing innovative catheter devices specifically designed for the treatment of patients suffering from pulmonary embolism (PE), including both massive and sub-massive cases. The company's technology combines the effectiveness of large bore thrombectomy with a user-friendly delivery method that reduces patient risks. Their mechanical clot removal system is engineered to capture and eliminate thrombus bulk efficiently, allowing physicians to navigate quickly to obstructed areas and restore hemodynamic stability in affected patients.
Nectin Therapeutics
Series A in 2022
Founded in 2017, Nectin Therapeutics develops novel monoclonal antibodies targeting the Nectin family of receptors and ligands. These antibodies aim to treat solid and hematological malignancies by modulating immune checkpoint mechanisms.
Cordio Medical
Venture Round in 2022
Founded in 2013, Cordio Medical develops a mobile application that monitors patients with congestive heart failure using their voice. The platform processes speech signals uniquely for each patient and employs machine learning to enable early detection of condition deterioration, helping physicians prevent hospitalization.
BrainQ
Venture Round in 2021
BrainQ develops a platform for precision neurology therapies using a Brain-Computer Interface (BCI) approach. Founded in 2016, the company is headquartered in Jerusalem, Israel.
Aleph Farms
Series B in 2021
Aleph Farms is an Israel-based food technology company that uses cellular agriculture to produce animal products in a sustainable and ethical way. Founded in 2017 and based in Ashdod, the company develops lab-cultured meat through proprietary three-dimensional bioprinting systems, using cells sourced from a living cow without slaughter. Its goal is to improve sustainability, food security and animal welfare in food systems, while bringing products to market under its Aleph Cuts brand. Aleph Farms has demonstrated cultivated products such as thin-cut steak and ribeye, as well as lab-cultured collagen, and plans to commercialize additional beef products grown from non-genetically engineered cells. The company emphasizes reducing environmental impact and advancing humane alternatives in meat production.
Aleph Farms
Series B in 2021
Aleph Farms is an Israel-based food technology company that uses cellular agriculture to produce animal products in a sustainable and ethical way. Founded in 2017 and based in Ashdod, the company develops lab-cultured meat through proprietary three-dimensional bioprinting systems, using cells sourced from a living cow without slaughter. Its goal is to improve sustainability, food security and animal welfare in food systems, while bringing products to market under its Aleph Cuts brand. Aleph Farms has demonstrated cultivated products such as thin-cut steak and ribeye, as well as lab-cultured collagen, and plans to commercialize additional beef products grown from non-genetically engineered cells. The company emphasizes reducing environmental impact and advancing humane alternatives in meat production.
BioProtect
Series D in 2020
BioProtect specializes in developing and commercializing biodegradable balloon spacers to protect normal tissue during cancer radiation therapy. Its flagship product, ProSpace, has demonstrated superior efficacy and safety in protecting the rectum during prostate cancer radiotherapy. BioProtect's technology platform caters to a wide range of applications for unmet clinical needs.
Hairstetics
Convertible Note in 2020
Founded in 2010, Hairstetics specializes in the development, manufacturing, and marketing of innovative medical devices for hair restoration. The company offers a range of solutions including surgical transplantation, non-surgical treatments, and advanced implantation techniques.
Payzday is a risk management solution provider based in Tel Aviv, Israel, that specializes in analyzing the risk levels of online merchants operating within marketplaces. Established in 2017, the company employs advanced technologies, including big data and artificial intelligence, to offer unprecedented visibility into merchant behavior. Payzday's approach goes beyond initial assessments during the onboarding process; it continuously monitors merchants in real-time, utilizing predictive analytics to identify potential unlawful or unstable situations. By providing financial institutions with detailed risk assessments, Payzday facilitates improved access to capital for online sellers, thereby enhancing their ability to secure necessary financing solutions.
SinuSafe Medical
Convertible Note in 2020
SinuSafe Medical develops a nano-debrider device for treating sinus conditions without surgical intervention. The device enables in-office sinus lavage with irrigation and aspiration, offering relief from chronic sinusitis for ENT patients. Founded in 2014 and headquartered in Tel Aviv, Israel, the company focuses on non-surgical, outpatient solutions for sinus care.
Restore Medical
Series A in 2020
Restore Medical develops a device-based therapy for congestive heart failure. Its product, ContraBand, is a catheter-delivered implant in the pulmonary arteries designed to improve patient quality of life and reduce hospital readmission rates.
Raziel Therapeutics
Series C in 2019
Founded in 2012 and based in Rehovot, Israel, Raziel Therapeutics develops RZL-012, a novel synthetic small molecule for treating obesity. Its drug is injected into fat tissue, causing fat cell death at the injection site and resulting in long-lasting reduction of fat volume.
Raziel Therapeutics
Series C in 2019
Founded in 2012 and based in Rehovot, Israel, Raziel Therapeutics develops RZL-012, a novel synthetic small molecule for treating obesity. Its drug is injected into fat tissue, causing fat cell death at the injection site and resulting in long-lasting reduction of fat volume.
Aleph Farms
Series A in 2019
Aleph Farms is an Israel-based food technology company that uses cellular agriculture to produce animal products in a sustainable and ethical way. Founded in 2017 and based in Ashdod, the company develops lab-cultured meat through proprietary three-dimensional bioprinting systems, using cells sourced from a living cow without slaughter. Its goal is to improve sustainability, food security and animal welfare in food systems, while bringing products to market under its Aleph Cuts brand. Aleph Farms has demonstrated cultivated products such as thin-cut steak and ribeye, as well as lab-cultured collagen, and plans to commercialize additional beef products grown from non-genetically engineered cells. The company emphasizes reducing environmental impact and advancing humane alternatives in meat production.
Magnisity
Venture Round in 2019
Magnisity is a medical technology company that develops novel surgical technology for minimally invasive procedures. Its platform integrates engineering, software development, hardware design, precision mechanics, and algorithms to create medical devices that support endoluminal interventions and help surgeons and patients overcome challenges in minimally invasive medicine. The company aims to advance future standards for such interventions through its integrated software, hardware, and engineering capabilities. Magnisity was founded in 2018 in Or Yehuda, Israel by Benny Greenburg and Ron Barak.
Payzday
Seed Round in 2018
Payzday is a risk management solution provider based in Tel Aviv, Israel, that specializes in analyzing the risk levels of online merchants operating within marketplaces. Established in 2017, the company employs advanced technologies, including big data and artificial intelligence, to offer unprecedented visibility into merchant behavior. Payzday's approach goes beyond initial assessments during the onboarding process; it continuously monitors merchants in real-time, utilizing predictive analytics to identify potential unlawful or unstable situations. By providing financial institutions with detailed risk assessments, Payzday facilitates improved access to capital for online sellers, thereby enhancing their ability to secure necessary financing solutions.
Hairstetics
Seed Round in 2018
Founded in 2010, Hairstetics specializes in the development, manufacturing, and marketing of innovative medical devices for hair restoration. The company offers a range of solutions including surgical transplantation, non-surgical treatments, and advanced implantation techniques.
CliClap Ltd., founded in 2016 and based in Kfar Saba, Israel, specializes in developing a content marketing utility for web browsers. This tool enhances audience engagement, brand awareness, and helps businesses achieve their goals by adding calls to action, scheduling posts, and analyzing success metrics. CliClap's AI-powered solution guides visitors through personalized content journeys, optimizing lead generation and qualification without manual management. The platform integrates seamlessly with existing marketing automation, CRM, social media management tools, and other systems, enabling more efficient marketing efforts and increasing conversion rates by at least 150%.
Cliclap
Seed Round in 2018
CliClap Ltd., founded in 2016 and based in Kfar Saba, Israel, specializes in developing a content marketing utility for web browsers. This tool enhances audience engagement, brand awareness, and helps businesses achieve their goals by adding calls to action, scheduling posts, and analyzing success metrics. CliClap's AI-powered solution guides visitors through personalized content journeys, optimizing lead generation and qualification without manual management. The platform integrates seamlessly with existing marketing automation, CRM, social media management tools, and other systems, enabling more efficient marketing efforts and increasing conversion rates by at least 150%.
Payzday
Seed Round in 2017
Payzday is a risk management solution provider based in Tel Aviv, Israel, that specializes in analyzing the risk levels of online merchants operating within marketplaces. Established in 2017, the company employs advanced technologies, including big data and artificial intelligence, to offer unprecedented visibility into merchant behavior. Payzday's approach goes beyond initial assessments during the onboarding process; it continuously monitors merchants in real-time, utilizing predictive analytics to identify potential unlawful or unstable situations. By providing financial institutions with detailed risk assessments, Payzday facilitates improved access to capital for online sellers, thereby enhancing their ability to secure necessary financing solutions.
Cordio Medical
Series B in 2017
Founded in 2013, Cordio Medical develops a mobile application that monitors patients with congestive heart failure using their voice. The platform processes speech signals uniquely for each patient and employs machine learning to enable early detection of condition deterioration, helping physicians prevent hospitalization.
Cordio Medical
Series A in 2017
Founded in 2013, Cordio Medical develops a mobile application that monitors patients with congestive heart failure using their voice. The platform processes speech signals uniquely for each patient and employs machine learning to enable early detection of condition deterioration, helping physicians prevent hospitalization.
NeuroApplied
Seed Round in 2016
Founded in 2016, NeuroApplied is a market research company that specializes in studying the collective subconscious of customers. It uses machine learning analytics and neural networks to analyze online picture games, providing clients with valuable insights into their customers' associative thoughts through its intuitive SaaS-based platform.
Eximo Medical Ltd. is an innovative company based in Modi'in-Maccabim-Re'ut, Israel, specializing in hybrid catheter technology for tissue resection in vascular and gastrointestinal endoluminal applications. Founded in 2012, Eximo has developed a proprietary single-use hybrid catheter known as CatHI, which integrates optical fibers that emit short laser pulses and a blunt mechanical knife. This advanced technology aims to enhance safety and performance during medical procedures, particularly in atherectomy, by minimizing the risk of vessel perforation. As of October 2019, Eximo Medical operates as a subsidiary of AngioDynamics, Inc.
SinuSafe Medical
Seed Round in 2016
SinuSafe Medical develops a nano-debrider device for treating sinus conditions without surgical intervention. The device enables in-office sinus lavage with irrigation and aspiration, offering relief from chronic sinusitis for ENT patients. Founded in 2014 and headquartered in Tel Aviv, Israel, the company focuses on non-surgical, outpatient solutions for sinus care.
ShapeDo
Pre Seed Round in 2014
ShapeDo Ltd. is a software development company based in Modi'in-Maccabim-Re'ut, Israel, founded in 2014. The company specializes in managing the implications of plan changes in construction projects through its cloud-based platform. ShapeDo's software facilitates comprehensive management of design changes, ensuring that all alterations are accurately reflected in contracts, budgets, and agreements. It provides functionalities such as blueprint version tracking, version comparison, and the generation of court-ready pricing reports, requests for information (RFIs), and claims. ShapeDo has been involved in significant infrastructure projects, including international airports, underground train systems, hospitals, and data centers, while also catering to smaller commercial and residential endeavors. Its solutions empower clients to navigate the complexities of design modifications and make necessary operational and financial adjustments seamlessly.
Cordio Medical
Seed Round in 2014
Founded in 2013, Cordio Medical develops a mobile application that monitors patients with congestive heart failure using their voice. The platform processes speech signals uniquely for each patient and employs machine learning to enable early detection of condition deterioration, helping physicians prevent hospitalization.
Jobrain
Seed Round in 2013
Jobrain Ltd. is a cloud-based hiring software provider based in Herzliya, Israel, designed to streamline the recruitment process for HR professionals and candidates. The platform enables candidates to apply for jobs easily while assisting HR teams in quickly identifying and hiring suitable talent. Jobrain features an open marketplace that offers a range of talent acquisition services, including job post distribution, remote and one-way video interviews, and candidate assessments. The company caters to head-hunters, agencies, and various hiring services, facilitating access to over 100,000 job positions, primarily in software development and startups. By leveraging data science, Jobrain simplifies the hiring process through a single interface, allowing clients to focus on essential tasks while minimizing administrative burdens.
Zuznow is an Israeli company founded in 2009 that specializes in mobile adaptation solutions for websites. Its platform automates the analysis of a website's visual structure and adapts it for optimal viewing on smartphones, facilitating a seamless mobile experience. Zuznow's technology serves a diverse clientele, including notable companies such as VentureBeat, HOOP, Newsgeek, and BAKER TILLY. The platform offers rapid mobile application development capabilities, allowing businesses to efficiently create secure mobile applications from complex web structures. This comprehensive solution supports various enterprise applications, including B2B, B2C, and B2E, effectively reducing development time and costs by over 90%. Zuznow positions itself as a key resource for organizations looking to implement a sustainable mobile strategy in response to the increasing demand for mobile-friendly solutions.
MarketYze
Seed Round in 2012
Marketyze is a technology company specializing in e-commerce market intelligence for the retail industry. Founded in December 2011 in Israel by Onn Manelson and Nave Ronen, the company provides a cloud-based platform that offers semantic site search and online price comparison solutions. Its pricing intelligence software tracks and analyzes competitor pricing, market trends, and internal data, enabling retailers to understand the impact of pricing events on sales performance. By leveraging this information, companies can refine their pricing strategies to enhance both sales and profitability.
ArTack Medical
Seed Round in 2012
ArTack Medical is a privately held medical device company based in Haifa, Israel, established in 2013. The company focuses on developing innovative tools for the invasive surgery market, particularly through its patented drive platform that enables the delivery of torque via a 5mm shaft. ArTack Medical's key product is an articulated hernia mesh fixation device designed to facilitate both laparoscopic and open surgical repairs. This device is compatible with any currently available mesh and allows surgeons to maintain their standard surgical techniques, thus enhancing operational efficiency without necessitating changes to established procedures.
CartiHeal
Series C in 2011
CartiHeal Ltd. is a medical device company based in Kfar Sava, Israel, specializing in the development of innovative solutions for cartilage and bone disorders. Founded in 2009, the company has pioneered a cell-free implant technology known as Agili-C, designed to address focal articular cartilage and osteochondral defects. This off-the-shelf implant promotes the regeneration of true hyaline cartilage and its underlying subchondral bone through a minimally invasive procedure, without the need for cells or growth factors. CartiHeal's Agili-C implant represents a significant advancement in the treatment of cartilage injuries, which can lead to severe pain, disability, and early onset of osteoarthritis if left untreated. By offering a well-tolerated and effective solution, CartiHeal aims to meet a critical need in the field of cartilage repair and regeneration.
Eximo Medical Ltd. is an innovative company based in Modi'in-Maccabim-Re'ut, Israel, specializing in hybrid catheter technology for tissue resection in vascular and gastrointestinal endoluminal applications. Founded in 2012, Eximo has developed a proprietary single-use hybrid catheter known as CatHI, which integrates optical fibers that emit short laser pulses and a blunt mechanical knife. This advanced technology aims to enhance safety and performance during medical procedures, particularly in atherectomy, by minimizing the risk of vessel perforation. As of October 2019, Eximo Medical operates as a subsidiary of AngioDynamics, Inc.
Valire is a software solution company based in HaMerkaz, Israel, founded in 2009, that specializes in artificial intelligence applications for fraud detection and risk assessment. The company focuses on developing innovative software that protects businesses' assets and reputations by identifying fraudulent behavior through a combination of business rules and symbolic machine learning. Valire's technology aims to minimize false positives and presents a cost-effective implementation, helping organizations reduce operational risks while optimizing their performance and growth opportunities.
CartiHeal
Series A in 2009
CartiHeal Ltd. is a medical device company based in Kfar Sava, Israel, specializing in the development of innovative solutions for cartilage and bone disorders. Founded in 2009, the company has pioneered a cell-free implant technology known as Agili-C, designed to address focal articular cartilage and osteochondral defects. This off-the-shelf implant promotes the regeneration of true hyaline cartilage and its underlying subchondral bone through a minimally invasive procedure, without the need for cells or growth factors. CartiHeal's Agili-C implant represents a significant advancement in the treatment of cartilage injuries, which can lead to severe pain, disability, and early onset of osteoarthritis if left untreated. By offering a well-tolerated and effective solution, CartiHeal aims to meet a critical need in the field of cartilage repair and regeneration.
Valtech Cardio
Seed Round in 2007
Valtech Cardio Ltd. is a medical device company based in Or Yehuda, Israel, founded in 2006. It specializes in the development and manufacturing of cardiovascular devices aimed at treating mitral and tricuspid valve regurgitation through minimally invasive techniques. The company’s flagship products include the Cardioband System, which reconstructs the mitral valve via transfemoral direct annuloplasty, and the Cardiovalve system, designed for transfemoral transseptal mitral valve replacement. Additionally, Valtech offers the Cardinal, an adjustable annuloplasty ring that allows surgeons to optimize valve repair during surgery. The company is also advancing its pipeline with products like Cardioband Tricuspid, aimed at mitral regurgitation treatment, and the V-Chordal, which addresses mitral valve prolapse. Valtech Cardio operates as a subsidiary of Zeppelin Zox Ltd.
Kailight Photonics
Series B in 2006
Kailight Photonics develops optical modules for the telecommunications industry. It offers tunable optical signal regenerator, an optical component that operates with regenerators, optical switches, add/drop multiplexers, and cross-connects. The company's optical transmission, signal regeneration, and wavelength conversion technology provides optical-networking solutions for systems vendors. It provides its products to long-haul network market segments. The company, formerly known as Chilight Technologies, was founded in 2000 and is headquartered in Rehovot, Israel with an additional office in Dallas, Texas. As of May 15, 2007, Kailight Photonics, Inc. operates as a subsidiary of Optium Corporation.